systolic/diastolic blood pressures were 60/22 mmHg. The patient was administrated salty isotonic serum. The oxygentherapy was carried with 10 μg/kg/minute dobutamine.
INTRODUCTION
Colchicine is Autumnal-Colchicum alkaloid extract used for antiinfl ammatory purposes. Acute colchicine-intoxication (CI) is rare leading to multi-visceral failure. CI severity depends of ingested doses. However, low-doses (5-10 mg) are fatal. [1] We discuss a-16-year-old-patient that ingested colchicine for suicidal purpose.
CASE REPORT
The patient was admitted in the emergency department after 6-hours of voluntary ingestion of 1 mg × 40 colchicine pill for suicidal purpose. This caused diffuse abdominal pains, vomiting, myalgia, and arthralgia. At-admission, the patient was awake with normochromic conjunctivas, the systolic and diastolic blood pressures were 90 mmHg of 65 mmHg, respectively, the cardiac frequency was 95 beats/minutes, and eupneic.
Gastric wash was achieved. Two-hours later, the patient presented shock state, frissons and profuse sweating. The family. It is used for anti-infl ammatory purposes. [2] The CI has a narrow therapeutic window and high potential of intoxication risk and might provoke a multi-visceral failure. [3] The colchicine consists fi xated on tubulin in a reversible and prolonged way. This stops the polymerization into microtubules. [4] This property is responsible for a cytostatic effect with cellular functions inhibition which is connected to infl ammation mechanisms.
C A S E R E P O R T

Fatal colchicine intoxication
The CI overdose expressed own toxicity on fast regeneration cells. This originates multi-visceral failure after a freeinterval of 6-12 h and appearance of digestive, respiratory, metabolic, hematologic, neurological, and cardiovascular disorders. [5] The hemodynamic instability, rhythm disorders, and appearance of infectious or hemorrhagic complications lead to fatal. Signs severity and mortality are associated with ingested doses although mortal cases are reported for lower doses of 5-10 mg. [5] The CI has strong morbidity for doses higher than 0.5 mg/ kg. The symptoms are digestive-disorders and decreased coagulation factors. Doses between 0.5-0.8 mg/kg demonstrated a death risk of 10% with additional medullar aplasia. Doses higher to 0.8 mg/kg are fatal with major refractory circulatory defi ciency in 72-h. [3] Our patient ingested 40 mg which demonstrated hemodynamic failure in the fi rst hour of admission and fi nally multi-visceral failure after 24 h of admission.
There is not any specifi c colchicine antidote, the CI therapy is symptomatic. This consists of gastric wash; ingestion of active-coal which that absorbs colchicine; hydroelectrolytics and proteins loss compensation, shock state correction and/ or catecholamines administration. [5] The mortality remains high despite the advanced medical care. [1] Considering colchicine distribution in tissue, exsanguino-transfusion, the hemoperfusion, and assisted-ventilation are not effective. [2, 5] How to cite this article: Labib S, Boujraf S, Berdai A, Harandou M. The immunotherapy using anti-colchicine polyclonal antibodies allows modifying the prognosis. Antibodies in a patient that ingested colchicine 60 mg with fatal prognosis were reported. Indeed the immunotherapy allows good evolution with fast correction of the biological/physiological disorders. [2, 5] However, these polyclonal anti-colchicine-antibodies are in preclinical study stage.
CONCLUSION
The CI originates high mortality with acute complications. The treatment is symptomatic. Early and suitable care would improve the prognosis. The immunotherapy using (45 kD) anti-colchicine allows improving critical form's prognosis.
